A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy

scientific article published on 22 February 2005

A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/428092
P698PubMed publication ID15747247
P5875ResearchGate publication ID7987432

P50authorRuth A KarronQ92344448
P2093author name stringWendy Chen
Ram Yogev
David P Greenberg
Paul M Mendelman
Sylvia H Yeh
Mark M Blatter
Min-Shi Lee
Keith S Reisinger
Joel I Ward
Julie M Cordova
Kathleen L Coelingh
Marilyn J August
Robert E Walker
Chithra Sangli
Lane Eubank
Harshvardhan B Mehta
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectinfancy stageQ49257364
P304page(s)1116-1122
P577publication date2005-02-22
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleA bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy
P478volume191

Reverse relations

cites work (P2860)
Q37468212A novel human parainfluenza virus type 1 (HPIV1) with separated P and C genes is useful for generating C gene mutants for evaluation as live-attenuated virus vaccine candidates
Q30229074Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus
Q42637687Characterization of a parainfluenza virus isolated from a bottlenose dolphin (Tursiops truncatus).
Q35751725Comparing the immune response to a novel intranasal nanoparticle PLGA vaccine and a commercial BPI3V vaccine in dairy calves
Q50619591Development of a PIV-vectored RSV vaccine: preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults.
Q37075237Differential gender response to respiratory infections and to the protective effect of breast milk in preterm infants
Q37164704Enterovirus 71 maternal antibodies in infants, Taiwan
Q37247449Experimental infection of adults with recombinant wild-type human metapneumovirus
Q36898701Human parainfluenza virus type 1 C proteins are nonessential proteins that inhibit the host interferon and apoptotic responses and are required for efficient replication in nonhuman primates
Q45351582Implication of respiratory syncytial virus (RSV) F transgene sequence heterogeneity observed in Phase 1 evaluation of MEDI-534, a live attenuated parainfluenza type 3 vectored RSV vaccine
Q59358405Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques
Q56894869Progress in respiratory virus vaccine development
Q34209872Progress in the development of human parainfluenza virus vaccines
Q38008607Recent developments with live-attenuated recombinant paramyxovirus vaccines
Q34175747Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1
Q37470206Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children
Q30235334The Role of Human Parainfluenza Virus Infections in the Immunopathology of the Respiratory Tract.
Q36617225The cell biology of acute childhood respiratory disease: therapeutic implications
Q47555408Vaccines for the Paramyxoviruses and Pneumoviruses: Successes, Candidates, and Hurdles
Q24201977Vaccines for the common cold
Q38682527Vaccines for the common cold

Search more.